Cushing Syndrome in Pediatrics

Endocrinology and Metabolism Clinics of North America

Volumn 41, Issue 4, 2012, Pages 793-803

  Stratakis, Constantine A ^a  

^a EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

Author keywords

Adrenal cancer; Adrenal cortex; Adrenocortical hyperplasia; Carney complex; Cortisol; Cushing syndrome; Pituitary tumors

Indexed keywords

AMINOGLUTETHIMIDE; CISPLATIN; CORTICOTROPIN; CYCLIC AMP; DOXORUBICIN; ETOPOSIDE; FLUOROURACIL; GLUCOCORTICOID; HYDROCORTISONE; KETOCONAZOLE; METYRAPONE; MITOTANE; SURAMIN; TRILOSTANE;

ADRENAL CORTEX CARCINOMA; ADRENAL INSUFFICIENCY; ADRENAL TUMOR; ADRENALECTOMY; AUTOIMMUNE DISEASE; BLEEDING; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; CORTICOTROPIN BLOOD LEVEL; CUSHING DISEASE; CUSHING SYNDROME; DEXAMETHASONE SUPPRESSION TEST; DIABETES INSIPIDUS; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; DRUG MECHANISM; ECTOPIC CORTICOTROPIN PRODUCTION; GAMMA KNIFE RADIOSURGERY; GENE; GNAS1 GENE; GROWTH HORMONE DEFICIENCY; HEMATOLOGIC DISEASE; HORMONE SUBSTITUTION; HUMAN; HYPERCORTISOLISM; HYPOGONADISM; HYPOPHYSIS APOPLEXY; HYPOTHYROIDISM; INAPPROPRIATE VASOPRESSIN SECRETION; INCIDENCE; LUNG DISEASE; MENINGITIS; NEOPLASM; NUCLEAR MAGNETIC RESONANCE IMAGING; PDE11A GENE; PDE8B GENE; PETROSAL SINUS SAMPLING; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PRKAR1A GENE; PROTEIN EXPRESSION; REVIEW; SEIZURE; SIGNAL TRANSDUCTION; SKIN DISEASE; SOCIAL PSYCHOLOGY; SOMATIC MUTATION; STEREOTACTIC RADIOSURGERY; TRANSSPHENOIDAL HYPOPHYSECTOMY;

ADENOMA; ADRENAL GLAND NEOPLASMS; CHILD; CUSHING SYNDROME; GLUCOCORTICOIDS; HUMANS; PITUITARY ACTH HYPERSECRETION; PITUITARY NEOPLASMS;

EID: 84867956024     PISSN: 08898529     EISSN: 15584410     Source Type: Journal    
DOI: 10.1016/j.ecl.2012.08.002     Document Type: Review

References (29)

1. Magiakou M.A., Mastorakos G., Oldfield E.H., et al. Cushing's syndrome in children and adolescents. Presentation, diagnosis, and therapy. N Engl J Med 1994, 331(10):629-636.
2. Lodish M.B., Sinaii N., Patronas N., et al. Blood pressure in pediatric patients with Cushing syndrome. J Clin Endocrinol Metab 2009, 94(6):2002-2008.
3. Tsigos C., Chrousos G.P. Differential diagnosis and management of Cushing's syndrome. Annu Rev Med 1996, 47:443-461.
4. Orth D.N. Cushing's syndrome. N Engl J Med 1995, 332(12):791-803.
5. Stratakis C.A., Kirschner L.S. Clinical and genetic analysis of primary bilateral adrenal diseases (micro- and macronodular disease) leading to Cushing syndrome. Horm Metab Res 1998, 30(6-7):456-463.
6. Stratakis C.A. Cushing syndrome caused by adrenocortical tumors and hyperplasias (corticotropin-independent Cushing syndrome). Endocr Dev 2008, 13:117-132.
7. Kirk J.M., Brain C.E., Carson D.J., et al. Cushing's syndrome caused by nodular adrenal hyperplasia in children with McCune-Albright syndrome. J Pediatr 1999, 134(6):789-792.
8. Fragoso M.C., Domenice S., Latronico A.C., et al. Cushing's syndrome secondary to adrenocorticotropin-independent macronodular adrenocortical hyperplasia due to activating mutations of GNAS1 gene. J Clin Endocrinol Metab 2003, 88(5):2147-2151.
9. Kirschner L.S., Carney J.A., Pack S.D., et al. Mutations of the gene encoding the protein kinase a type I-alpha regulatory subunit in patients with the Carney complex. Nat Genet 2000, 26(1):89-92.
10. Horvath A., Boikos S., Giatzakis C., et al. A genome-wide scan identifies mutations in the gene encoding phosphodiesterase 11A4 (PDE11A) in individuals with adrenocortical hyperplasia. Nat Genet 2006, 38(7):794-800.
11. Gunther D.F., Bourdeau I., Matyakhina L., et al. Cyclical Cushing syndrome presenting in infancy: an early form of primary pigmented nodular adrenocortical disease, or a new entity?. J Clin Endocrinol Metab 2004, 89(7):3173-3182.
12. Marx S.J., Agarwal S.K., Kester M.B., et al. Multiple endocrine neoplasia type 1: clinical and genetic features of the hereditary endocrine neoplasias. Recent Prog Horm Res 1999, 54:397-438. [discussion: 438-399].
13. Stratakis C.A., Tichomirowa M.A., Boikos S., et al. The role of germline AIP, MEN1, PRKAR1A, CDKN1B and CDKN2C mutations in causing pituitary adenomas in a large cohort of children, adolescents, and patients with genetic syndromes. Clin Genet 2010, 78(5):457-463.
14. Magiakou M.A., Chrousos G.P. Cushing's syndrome in children and adolescents: current diagnostic and therapeutic strategies. J Endocrinol Invest 2002, 25(2):181-194.
15. Batista D.L., Riar J., Keil M., et al. Diagnostic tests for children who are referred for the investigation of Cushing syndrome. Pediatrics 2007, 120(3):e575-e586.
16. Bornstein S.R., Stratakis C.A., Chrousos G.P. Adrenocortical tumors: recent advances in basic concepts and clinical management. Ann Intern Med 1999, 130(9):759-771.
17. Nieman L.K., Biller B.M., Findling J.W., et al. The diagnosis of Cushing's syndrome: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 2008, 93(5):1526-1540.
18. Yanovski J.A., Cutler G.B., Chrousos G.P., et al. Corticotropin-releasing hormone stimulation following low-dose dexamethasone administration. A new test to distinguish Cushing's syndrome from pseudo-Cushing's states. JAMA 1993, 269(17):2232-2238.
19. Batista D.L., Courcoutsakis N., Riar J., et al. Severe obesity confounds the interpretation of low-dose dexamethasone test combined with the administration of ovine corticotrophin-releasing hormone in childhood Cushing syndrome. J Clin Endocrinol Metab 2008, 93(11):4323-4330.
20. Louiset E., Stratakis C.A., Perraudin V., et al. The paradoxical increase in cortisol secretion induced by dexamethasone in primary pigmented nodular adrenocortical disease involves a glucocorticoid receptor-mediated effect of dexamethasone on protein kinase a catalytic subunits. J Clin Endocrinol Metab 2009, 94(7):2406-2413.
21. Chrousos G.P., Schulte H.M., Oldfield E.H., et al. The corticotropin-releasing factor stimulation test. An aid in the evaluation of patients with Cushing's syndrome. N Engl J Med 1984, 310(10):622-626.
22. Batista D., Courkoutsakis N.A., Oldfield E.H., et al. Detection of adrenocorticotropin-secreting pituitary adenomas by magnetic resonance imaging in children and adolescents with Cushing disease. J Clin Endocrinol Metab 2005, 90(9):5134-5140.
23. Oldfield E.H., Doppman J.L., Nieman L.K., et al. Petrosal sinus sampling with and without corticotropin-releasing hormone for the differential diagnosis of Cushing's syndrome. N Engl J Med 1991, 325(13):897-905.
24. Batista D., Gennari M., Riar J., et al. An assessment of petrosal sinus sampling for localization of pituitary microadenomas in children with Cushing disease. J Clin Endocrinol Metab 2006, 91(1):221-224.
25. Batista D.L., Oldfield E.H., Keil M.F., et al. Postoperative testing to predict recurrent Cushing disease in children. J Clin Endocrinol Metab 2009, 94(8):2757-2765.
26. Powell A.C., Stratakis C.A., Patronas N.J., et al. Operative management of Cushing syndrome secondary to micronodular adrenal hyperplasia. Surgery 2008, 143(6):750-758.
27. Lodish M., Dunn S.V., Sinaii N., et al. Recovery of the hypothalamic-pituitary-adrenal axis in children and adolescents after surgical cure of Cushing's disease. J Clin Endocrinol Metab 2012, 97(5):1483-1491.
28. Merke D.P., Giedd J.N., Keil M.F., et al. Children experience cognitive decline despite reversal of brain atrophy one year after resolution of Cushing syndrome. J Clin Endocrinol Metab 2005, 90(5):2531-2536.
29. Keil M.F., Merke D.P., Gandhi R., et al. Quality of life in children and adolescents 1-year after cure of Cushing syndrome: a prospective study. Clin Endocrinol (Oxf) 2009, 71(3):326-333.